FDA urgently warns consumers about the recall of 26 eye drops due to potential blindness risk.

Health

US FDA Urges Consumers to Avoid Certain Eye Drops Due to Risk of Infection

The US Food and Drug Administration (FDA) has issued a warning to the public regarding specific over-the-counter eye drop products. These eye drops, commonly used for dry eyes and eye irritation, have been linked to the potential risk of eye infections, including partial vision loss or blindness.

The brands in question include CVS Health Corp, Rite Aid, Cardinal Health, Target’s ‘up & up’ brand, and Velocity Pharma. While no adverse events have been reported, the FDA’s actions indicate that these products pose a significant threat to consumers.

The FDA’s warning follows an investigation into the manufacturing facilities of the implicated brands. Inspectors found unsanitary conditions, leading the FDA to urge a recall of all the products in question. Prompt responses from CVS, Rite Aid, and Target have resulted in the removal of the tainted products from store shelves and websites. These brands have also promised full refunds to customers who return the product. However, products under the brands Leader, Rugby, and Velocity may still be available for purchase despite the FDA’s concerns.

The eye drops under scrutiny are intended to be sterile, as contamination can have severe consequences. Ophthalmic drug products pose a higher risk due to direct application to the eyes, bypassing natural defenses. The FDA advises consumers to discard these products and seek medical attention if they experience any signs of an eye infection after use.

While no adverse events have been reported, the urgency of the FDA’s warning emphasizes the seriousness of the situation. In addition, the FDA recently cautioned eight companies, including CVS and Walgreens Boots Alliance, against manufacturing or marketing unapproved eye products.

If you or someone you know has been affected by these products or suspects quality problems or adverse events related to any medication, the FDA encourages reporting through the MedWatch Adverse Event Reporting program.

Please note that this article is © 2023 TECHTIMES.com. All rights reserved. Do not reproduce without permission.

Tags: FDA, eye drops, eye infections, product recall, health risks.